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1. Introduction 
Technical advances in Vascular Surgery have led to an increased use of prostheses (grafts, 
patches, stents, stent grafts etc.) and improved results for the patient. Despite routine 
antibiotic prophylaxis, infection, although rare, remains a serious complication, with 
catastrophic consequences. Vascular infections are divided into 3 groups according to 
Szilagyi (Table 1.), depending on the extent of the inflammation: the superficial, the deep 
and the mixed type.[1] Samson (Table 1.), as well as Karl and Storck (Table 1.) , have 
modified the widely used classification system of Szilagyi.[1-3] While the superficial type is 
restricted to the skin and subcutaneous tissue, the deep infection involves the vessels or a 
prosthetic graft. The mixed type of vascular infection is the combination of the above types 
affects all the tissue layers and can produce trauma disruption. Vascular infections can be 
classified by appearance time into: a) early (<4 weeks after graft implantation) and b) late (>4 
weeks). Samson’s and Karl’s modifications take into consideration further clinical 
parameters, which define the treatment (Table 2.). [2,3] When infection involves a graft 
anastomosis or the suture line of a patch, there is high risk of vessel rupture, septic 
hemorrhage or pseudoaneurysm formation. [4-6] Other serious complications are septic 
thrombosis, endocarditis, etc. [7] In severe cases, treatment can be problematic and mortality 
remains high, despite the use of antibiotics and surgical treatment. Keys to successful 
outcome include early and accurate diagnosis, identification of the infecting organism, and 
extent of graft infection, administration of culture-specific antibiotic therapy, and excision or 
replacement of the infected graft. 
2. Epidemiology 
The reported incidence of infection involving vascular prosthesis varies, occurring after 
0.2% to 5% of vascular procedures . [4] The long - term incidence is possibly higher than that 
reported, since some graft infections (e.g. aortic graft infections) develop several years after 
implantation . [8] 
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Table 1. Classification of vascular graft infections 
 
Grade Clinical findings Recommendation 
Szilagyi I, Samson I
 
Infection involves only cutis Conservative treatment 
Szilagyi II, Samson II, 
Karl I 
Cutis/subcutis infection without 
graft involvement 
a) graft preservation combined with 
VAC 
b) graft excision 
Szilagyi III, Samson 
III, Karl II 
Deep graft infection without 
involvement of anastomosis or 
suture line 
a) graft preservation combined with 
VAC 
b) graft excision 
Szilagyi III, Samson 
IV, Karl III-IV 
Deep graft infection with 
involvement of anastomosis or 
suture line 
a) graft excision 
b) graft preservation combined with 
VAC 
Szilagyi III, Samson 
V, Karl V-VI 
Deep graft infection associated 
with complications (bleeding, 
thrombosis, suture aneurysm) 
graft excision 
Table 2. Therapeutic recommendations depending on the infection grade 
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Incidence of vascular infections is influenced by patient’s general condition, the type of the 
procedure, the coexistence of other simultaneous inflammation sites, the type of 
prophylactic antibiotics given perioperatively and by prolonged operative time and hospital 
stay . [9-13] Infections are much more frequent in the groins (60% of cases), in grafts placed 
in a subcutaneous tunnel and after emergency cases (e.g. acute arterial ischemia). Infection 
can also develop after percutaneous stent angioplasty but in low rates (0.5%). [14,15] 
Early graft infections usually affect extracavitary grafts, while majority of late infections 
involve cavitary (i.e., aortic) grafts. [16] 
3. Pathogenesis 
Exposure of vascular grafts to bacteria, irrespective of source, may result in colonization and 
subsequent infection. Microorganisms can result in clinical infection most commonly, 
perioperatively, during surgical implantation or through the surgical wound. The most 
common mechanisms of infection are: break of aseptic techniques in the operating room and 
contact of the graft with patient’s endogenous flora harboured in lymphatics rupturing 
intraoperatively, sweat glands or mucosas. Intraoperative injury of gastrointestinal or 
genitourinary tract, diseased arterial wall, healing problems of surgical wound and 
reoperations can result in graft infection. [4] 
Bacterial contamination of the prosthesis via a hematogenous route is rare, though urinary 
tract infections, infected intravascular catheters, pneumonia or other remote tissue infections 
(e.g. infected foot ulcer) increase the risk of graft infection. Bacteremia can result in graft 
infection, years after the implantation, especially in elderly patients with altered immune 
status. 
Moreover, erosion of a prosthetic graft through the skin or into the gastrointestinal or 
genitourinary tract can lead to an infection. GEE/GEF can develop due to pulsatile pressure 
transmitted via an aortic graft to the overlying adherent bowel, usually the third part of the 
duodenum. This can be prevented by coverage of the graft by adjacent omentum at the end 
of the procedure. A graft-cutaneous fistula by erosion through intact skin is most commonly 
the result of a low-grade infection caused by S. epidermidis.  
Finally, grafts can get contaminated by a contiguous infectious process as a result of an 
adjacent infection (e.g. diverticulitis, infected lymphocele). 
 Predisposing factors for vascular infection are the use of prosthetic grafts, procedures in the 
groins, local or systemic septic conditions, while the predicting factors are patient’s immune 
status, graft’s characteristics, prolonged hospital stay , bacterial virulence or resistance to 
antibiotics. Additionally, reoperations, long or emergency procedures, faulty sterile surgical 
technique, postoperative complications (such as hematoma, graft thrombosis) and 
concomitant urological or biliary and colon operations contribute to increased rates of 
vascular infections. [17] 
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4. Bacteriology 
Staphylococci (Staphylococcus aureus and coagulase negative staphylococci) account for more 
than 75% of vascular device-related infections. In fact, S. aureus is the most prevalent 
pathogen. Graft infections due to S. epidermidis or gram-negative bacteria have increased in 
frequency. Less frequently, microorganisms of the skin flora, such as streptococci and 
Propionibacterium acnes, are isolated.  
Gram-negative bacteria such as Pseudomonas, E. coli, Klebsiella, Enterobacter, and Proteus 
species are particularly virulent, followed by high rates of anastomotic disruption. This can 
be explained by their ability to produce toxins, such as elastase and alkaline protease, which 
can decompose the arterial wall. [18,19] 
MRSA (Methicillin-resistant S. aureus) vascular infections present with increased incidence. 
[20] Fungal infections  are rare and develop usually in immunosuppressed patients. 
 Early infections are usually caused by especially virulent microorganisms, such as S. 
aureus, Streptococcus faecalis, E. coli, Pneumococcus, Klebsiella and Proteus. Late infections 
are the result of low-virulence microorganisms such as S. Epidermidis.  
5. Clinical manifestations 
Clinical manifestations vary according to the localization of the vessel that is involved. Graft 
infections in limbs (e.g. femoropopliteal graft) present with edema, cellulitis or with a 
pulsatile mass, in case anastomotic rupture and pseudoaneurysm formation. According to 
Szilagyi, vascular infections can be classified by relationship to postoperative wound 
infection. Graft contamination in the abdominal (Table 3.) or thoracic cavity, usually 
presents with systematic sepsis, aortoenteric, and aortobrochial or aortooesophageal fistula. 
Symptoms in early infections can be fever, leukocytosis and perigraft purulence. 
Patients with aortic grafts and gastrointestinal bleeding should be investigated for GEE. 
[21,22] Bacteremia develops in advanced graft infections. Graft infection due to S. 
epidermidis typically presents months to years after graft implantation with anastomotic 
aneurysm, graft-cutaneous sinus tract or perigraft cavity with fluid. Vascular Surgeon 
should, also, look for other sources of infection, (e.g. feet or urinary infections). 
6. Diagnosis 
6.1. Laboratory testing 
Early diagnosis is crucial for treatment and for prevention of septic complications that can 
threaten the affected limb or even patient’s life. It is based on physical examination  and 
imaging modalities. Blood tests results are non-specific for vascular infection, with low 
diagnostic value. Elevated WBC count with left shifted differential, increased erythrocyte 
sedimentation rate or high levels of CRP can be found during the acute phase. Blood 
cultures are rarely positive (˂5%) but such findings, in addition with high fever, are markers 
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of advanced infection and sepsis. In these cases, early hospital admission and treatment are 
essential. Laboratory tests should include cultures from other sites of infection and stool 
guaiac, in case GEE is suspected. 
 
Table 3. Classification of aortic graft infection (Bandyk 1991) 
6.2. Vascular imaging  
Vascular imaging is of crucial significance in the diagnosis and treatment planning of 
vascular infections. Imaging modalities that are useful for diagnosis are ultrasonography, 
CT Angiography, MR Angiography, endoscopy or functional radionuclide imaging (indium 
111-labelled leukocytes). The combination of anatomic and functional vascular imaging 
techniques shows high sensitivity (80% to 100%) and specificity (50% to 90%) in 
identification of infection. 
Plain radiographs are of limited value, providing information only in the case of prosthesis 
misplacement or dislocation. 
Color duplex scanning is a readily available imaging technique, reliable for diagnosis of 
perigraft fluid collection, which can be differentiated from anastomotic pseudoaneurysms, 
especially in extracavitary infections. Imaging of abdominal cavity or aortic grafts is not 
accurate in obese patients. Graft patency can be easily examined. 
Contrast-enhanced CT is the preferred imaging technique for abdominal or thoracic aorta 
graft infections. Signs of abnormal fluid or gas collections around the prosthesis (beyond 2-3 
months of implantation) or false aneurysm formation are suggestive of infection. Loss of 
normal retroperitoneal tissue planes or vertebral osteomyelitis in a patient with an aortic 
graft indicates a vascular infection. CT-guided aspiration is being increasingly used to 
differentiate perigraft abcesses from seromas. 
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MRA is an alternative modality to CTA, with equal specificity or sensitivity. It can also 
differentiate perigraft fluid from adjacent fibrosis. Gadolinium is less nephrotoxic in patients 
with renal insufficiency. However, it is contraindicated in patients with electrophysiological 
devices. The presence of metallic materials may cause artefacts that compromise image quality. 
The use of arteriography is useful in the identification of anastomotic aneurysms or other 
graft complications (e.g. graft rupture) and for the evaluation of the vascular tree before 
revascularization planning. It should be a routine examination in hemodynamically stable 
patients with graft infection unless CT or MRI scans give the above type of information. 
Functional White Blood Cell Scanning is indicated in special cases. 99mTc-labelled white 
blood cells, 111In or gallium scintigrams are most commonly used along with MRI and CT 
to define the extent of graft involvement. Positive predictive value of the functional imaging 
scans ranges between 80% to 90% in the detection of graft infection. False-positive results 
are not uncommon during the early postoperative period.  
Endoscopy is very useful in cases of suspected secondary aortoenteric erosion or fistula and 
is an emergency procedure in patients with massive gastrointestinal bleeding where it can 
be performed in the operating theatre, with the patient prepared for operation. It is 
important is to visualize the third and fourth part of duodenum and rule out other sources 
of gastrointestinal bleeding. Though, an aortoduodenal fistula cannot be excluded by 
negative findings. 
7. Operative findings 
Operative exploration is sometimes mandatory for the final diagnosis, especially in unstable 
patients or in cases with a history of aortic grafting and gastrointestinal bleeding, where a 
GEF is suspected. Unfortunately only 50% of GEFs can be diagnosed by CT or MRI 
modalities. Operative exploration, graft excision and broth culture of the graft can lead to 
isolation of the responsible microorganisms and selection of proper antibiotic treatment. 
8. Prevention 
Prevention of graft contamination perioperatively is of great importance, given the high 
mortality and morbidity that follows a vascular infection. Antimicrobial prophylaxis should 
be administered within 60 min before incision and discontinued within 24 h after surgery. 
According to the published consensus of the Surgical Infection Prevention Guideline Writers 
Workgroup (SIPGWW), the recommended prophylactic antibiotics for cardiothoracic and 
vascular surgery include cefazolin and cefuroxime. [23] For intra-abdominal surgery 
coverage for anaerobes may be added (metronidazole). [24] 
Culture-specific antibiotics should be administered to patients who have coexisting 
infections. 
There are some principles that should be followed perioperatively, in order to prevent an 
infection:  
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 Patients should scrub the night before the operation 
 Hair of the operative site should be removed by clippers and not by razors so as to 
prevent skin trauma 
 Preoperative hospital stay should be minimized, if possible 
 Remote infections must be controlled before elective grafting interventions 
 Concomitant gastrointestinal procedures should be avoided, if a graft is planned to be 
used (cholecystectomy for asymptomatic cholelithiasis is possibly excepted) 
 The use of iodine-impregnated plastic drapes is recommended, so as to prevent graft 
contamination 
 Meticulous sterile technique is vital 
 Careful hemostasis and closure of surgical incisions in multiple layers are 
recommended 
 Irrigation of groin wounds with topical antibiotics before closure may decrease 
infection rates. [25] 
9. Therapeutic management of vascular infection 
9.1. General principles 
Presentation of vascular infections varies and there is, usually, no standard treatment. 
Treatment should be individualized according to infection site, clinical presentation and the 
isolated microorganisms. For the extracavitary graft infections there are some 
recommendations, based on infection grade, simplifying the complexity of treatment. (Table 
2) The main goal is eradication of the infection while preserving blood flow to the target 
organs or limbs. 
Preparation of the patient is important, though takes time. In unstable patients due to septic 
or hypovolemic shock, no delay is justified. Blood or fluid resuscitation, antibiotic coverage 
and urgent surgical treatment are the only option. For the rest of the cases, where time is 
available, patient’s cardiac, pulmonary and renal function should be optimized. Diabetic 
patients must have their glucose levels controlled. Malnourished patients can improve by 
enteral or parenteral nutrition. When an abdominal operation is planned, colon should be 
mechanically, cleansed. A Duplex scan of the lower limb veins is recommended, especially 
in cases of in situ replacement with autologous graft. Preoperative antibiotic coverage of the 
patient is crucial. 
Available options include graft excision with or without revascularization and graft 
preservation with local treatment. Graft excision can be followed by extra anatomic 
revascularization or in situ replacement of the graft.  
9.2. Preservation of the graft 
Preservation of the infected graft is indicated in few, selected cases, usually when infection 
involves autologous vein grafts or patches. [26-28] Patients must have no signs of sepsis and 
the graft should be patent with segmental contamination. Anastomoses must be spared.  
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Outcome is better with vein or PTFE than polyester grafts, with early than late infections (˂4 
months) and with extracavitary grafts. Infections caused by single Gram positive and not 
multiple Gram negative organisms (e.g. Pseudomonas) may be considered for graft 
preservation and local treatment.  
Local treatment includes staged surgical debridement of infected tissues in healthy plane, 
mechanical irrigation of the wound (using povidone iodine solution and peroxide), on a 
regular basis, rotational muscle flap coverage, temporary use of antibiotic impregnated 
beads and VAC devices (vacuum assisted closure devices for wounds). Intravenous culture-
based antibiotics are essential. Persistent infection or sepsis is an indication of treatment 
failure which happens in 30% of the patients. [27] In such cases, graft excision with or 
without revascularization should follow.  
9.3. Graft excision 
Graft excision without revascularization is rarely an option, mostly in patients where the 
indication for the initial procedure was claudication, or in cases where the infection has led 
to graft thrombosis but with no signs of critical ischemia. In patent infected grafts, the 
decision regarding the need for immediate revascularization is based on temporary graft 
occlusion. The presence of Doppler pedal pulsatile signal and systolic ankle pressure greater 
than 40 mmHg is a sign of sufficient preexisting collaterals. In cases of infected bypass grafts 
with end to side anastomosis, the graft can be removed and an autologous patch can be 
placed at the site of proximal anastomosis. 
In the majority of the cases, graft excision should be accompanied by revascularization of 
the target organs or limbs, usually by means of extra-anatomic PTFE bypass, through 
uninfected tissues.  
This technique is suitable, mainly for aortoiliac or aortobifemoral infected grafts, for patients 
with GEE/GEF or for more diffuse infections with signs of systemic sepsis. Graft excision 
can be accomplished through celiotomy or left-side retroperitoneal incision, so as to avoid 
contaminated areas. Preoperative stenting of the ureters is recommended in cases of 
extensive infection, for protection during dissection and easier identification. Supraceliac 
aortic clamping and control of iliac arteries (at healthy segments, distally to the infected part 
of the graft) may be necessary, though sometimes difficult due to perigraft inflammation. 
Some centers advocate the use of intraluminal occlusion balloons. Meticulous dissection of 
the adherent viscera’s or duodenum, especially in patients with GEE/GEF is important. 
Necrotic bowel segments must be excised and bowel continuity should be restored by end 
to end anastomosis. Complete removal and culture of the aortoiliofemoral graft must follow. 
Extensive debridement and irrigation (by use of cytotoxic agents) of perigraft contaminated 
or necrotic tissues are essential. Closure of the aortic stump is performed by double layers of 
interrupted monofilament sutures. Prosthetic pledgets should be avoided. Coverage of the 
aortic stump with omentum pedicles is believed to prevent stump blowout and its 
catastrophic consequences. The same technique can be applied for the ligation of iliac 
arteries, but flow must be maintained at least to one hypogastric artery, in order to avoid 
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pelvic or colon ischemia. Placement of closed suction drains can be placed in the 
retroperitoneal space. Reported mortality rates range between 11-22%, while limb loss 10-
11%. [20,29] Stump blowout, which is a major complication, can happen up to 22% of the 
cases. [7] 
Several authors suggest that staged management of infected aortic grafts, show lower 
morbidity and mortality rates. [29,30] Hemodynamically unstable patients, are an exception, 
and the vascular surgeon should focus on the site of hemorrhage (septic hemorrhage from 
anastomosis, GEE/GEF). In the rest of the cases, it is recommended, to perform the extra-
anatomic bypass first, and graft excision can follow 1 to 2 days later. 
Aortobifemoral graft infections, especially in the groins, constitute a challenge for the 
surgeon. Unilateral ex situ bypass to the profunda femoris or superficial femoral artery 
through uninfected planes is an option, while bypass to the popliteal artery results in low 
rates of patency (58% in 6 months). [31] In bilateral groin infections, graft excision followed 
by unilateral axillofemoral bypass and autogenous vein cross-femoral bypass is another 
solution. 
In-situ graft replacement is an alternative solution, in selected cases. There should be no 
systemic signs of sepsis, any anastomotic bleeding or perigraft incorporation. Perigraft fluid 
cultures must be sterile unless bacteria of low virulence, such as S. Epidermis, are isolated. 
In fact, in patients with infection that involves the thoracic aorta or the visceral segment of 
abdominal aorta, in situ replacement may be the only option available. The most common 
grafts used in this technique are autologous grafts (e.g. superficial or deep veins of the 
limbs), antibiotic bonded prosthetic grafts or cryopreserved arterial allografts. (Figure 1.) 
Great saphenous vein (GSV) or superficial veins from the upper limb can be used in cases 
where infection affects infrainguinal, upper extremity, visceral or cerebrovascular 
procedures. A preoperative Duplex vein mapping is essential for estimation of vein’s 
condition and diameter. 
However, use of GSV in ilio-femoral or aorto-iliac reconstructions, results in low patency 
rates, due to diameter mismatch. [32] In these cases, superficial femoral vein harvesting has 
a strong indication. [33,34] Preoperative vein mapping is important. In cases of aortic 
reconstruction, with larger aortic diameter, “pantaloon technique” can be applied. (Figure 
1.) Compared to graft excision and extra anatomic bypass, in situ graft replacement presents 
better patency and recurrent infection rates. [35] Superficial femoral vein can be used also, in 
aortofemoral graft infections localized in the groin caused by S. epidermidis. However its use 
in secondary GEE/GEF is not recommended. Deep veins are used non reversed, after valve 
excision. 
Antibiotic bonded prosthetic grafts (PTFE or Dacron), can be used in segmental graft 
infections, where the isolated microorganism is of low virulence (e.g. S. Epidermidis) and 
the anastomoses are spared. [20] For example in segmental aortofemoral graft infections, 
with groin complications, especially in elderly patients, antibiotic bonded prosthetic grafts 
should be considered for replacement of one limb of the pre-existing graft. 
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Figure 1. In situ aortic reconstruction after graft infection (A= infected bifurcated graft, B= autologous 
replacement (“Pantaloon” technique),  C= heterologous replacement (bovine aorta),D= Repair with 
silver-bonded synthetic graft) 
An alternative option, especially in more diffuse infections, is the use of cryopreserved 
arterial allografts. While the survival and recurrent infection rates are comparable to other 
grafts, increased dilation (17%) and stenosis (20%) rates were noticed. [36] 
Overall, outcomes following deep venous replacement are better than with the use of 
arterial allografts or implantation of a “new” prosthetic graft. When applied to low-grade 
aortic graft infections without GEE or GEF, this procedure is safe (4% in-hospital mortality), 
with a low (3%) incidence of long-term limb loss. In cases with GEE/GEF, mortality can 
reach 20%, similar to graft excision and ex-situ bypass. 
10. Adjunctive treatments 
10.1. Antibiotic-loaded beads 
In vascular infections, where graft preservation and serial debridement of the wound is the 
selected treatment, implantation of antibiotic –loaded beads is an alternative adjunctive 
therapy. They are mainly used in extracavitary graft infections. Beads are usually loaded 
with vancomycin, daptomycin, tobramycin, or gentamicin based on initial culture results. 
Initial results are encouraging, with wound healing in 90% of the cases. [37] 
10.2. Muscle flap coverage  
Infected grafts that are treated locally must be surrounded by healthy, non contaminated 
tissues. Coverage of the graft with a well vascularised, not infected muscle flap, contributes 
to wound healing. Sartorius muscle flap coverage is the most common technique used in 
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graft infections located in the groins. [38] This technique is mainly indicated, as an adjunct 
of graft preservation or in situ replacement therapies, especially in cases of recurrent 
infections or extensive tissue deficit after debridement. The muscle is divided from its 
proximal attachment to the iliac crest and sutured medially, so as to cover the infected graft. 
In a published series, recurrent infection rate after use of Sartorius flap was only 7%. [39] 
Another similar technique is the rotational use of flaps of muscles that are mobilized from a 
separate healthy site. Their blood supply doesn’t come from the infected area. The gracilis 
rectus abdominis, tensor fasciae latae or rectus femoris can be used, depending on site of 
infection. [40] Some authors consider this technique as a better option than the use of 
Sartorius muscle. [38] 
10.3. Antibiotics 
When the diagnosis of vascular infection is made, parenteral broad spectrum antibiotics 
should be given, until isolation of the infecting micro-organism is accomplished, through 
cultures. Additionally, if cultures reveal no pathogen or there are no available specimens for 
culture, empiric antimicrobial treatment should target skin-colonizing organisms and 
nosocomial pathogens as well. 
Vancomycin is an indispensable agent in the initial empiric antimicrobial regimen, because 
of its excellent anti-Gram-positive spectrum. Teicoplanin has a similar antimicrobial 
spectrum to vancomycin but has not been tested in large prospective series for the treatment 
of vascular infections. [41-44] 
Alternative antimicrobial agents are linezolid and quinupristin/dalfopristin, which provide 
coverage for methicillin-resistant staphylococci (MRSA and MRSE) and vancomycin-
resistant enterococci (VRE). Their use should be reserved for infections due to pathogens 
resistant to vancomycin, or in patients who are allergic to vancomycin. [45,46] 
Once cultures reveal the infecting pathogen , parenteral antibiotic treatment should be 
initiated, without any delay. 
The duration of therapy is individualized but most authors recommend 4–6 weeks of 
treatment after the removal of the infected graft. 
11. Management of specific graft site infection 
11.1. Carotid infection  
Depending on grading, carotid artery infections are reported up to 2% of cases. [47] Szylagyi 
III infections are found in a rate of less than 1%. [48,49] The majority of infections are 
postoperative wound contaminations, which seldom extent to the suture line. Wound 
dehiscence with septic haemorrhage is extremely rarely observed. There are reports that the 
use of prosthetic materials increases the infection rate. However, the management of such 
infections that may lead to catastrophic life-threatening septic complications is especially 
challenging. The standard treatment includes wound debridement and prosthetic graft 
 Vascular Surgery – Principles and Practice 42 
replacement with autologous material (e.g. saphenous vein). Recently the use of 
sternocleidomastoid muscle flap plasty for coverage of the infected area was described. 
More recently, carotid stent infections were reported in up to 0,4 % of cases. [48] This 
complication may present primary or secondary to neck irradiation and trauma. [48,50,51] 
The treatment principles are similar to post-CEA infections. The use of vacuum assisted 
closure device emerges as a new trend with promising results. [52]  
11.2. Infection of vascular access 
Vascular access Infection is a major complication for haemodialysis patients. Clinical 
symptoms vary from simple local inflammation to systemic sepsis. In some cases, septic 
haemorrhage may develop, which is a life-threatening condition. (Figure 2.) Reported risk 
factors for this adverse event include immunodeficiency, low serum albumin level, female 
gender, adult polycystic kidney disease, diabetes mellitus, inadequate dialysis and the use 
of catheters or synthetic graft. [53] It is estimated that 30 to 50% of bacteraemia in 
haemodialysis patients is caused by vascular access infection. [53] There are reports that 
infection rates range from 0.5 to 3.5% for autogenous AVF, 5-8% for prosthetic graft accesses 
and 2-5.5 episodes of bacteremia per 1000 patient days for central venous catheters. [54,55] 
 
Figure 2. Infection of brachio-cephalic fistula (Cimino) at the wrist with septic bleeding 
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Early postoperative graft infections usually affect the whole graft. The treatment of choice is 
excision of the entire graft. Late localised infection at the needles sites can be managed by 
segmental graft removal and bypass through uninfected planes. Sometimes, though, total 
excision is necessary. 
The use of V.A.C. as an adjunctive treatment may be beneficial. Autogenous AV access 
infections often can be effectively treated with systemic antibiotics. In case of infected 
pseudoaneurysms or abscesses access ligation of the access or segmental bypass are 
mandatory. 
Catheter infection presentation varies. Exit-site infections are treated with local antibiotics. 
In case of failure, parenteral antibiotics should be administered. Tunnel tract infections 
require intravenous antibiotics, and catheter exchange through a new tunnel and exit site. 
These patients require at least 3 weeks of culture-based antibiotic therapy and monitoring 
for recurrent infection. [56] Patients with systemic sepsis should have their catheter removed 
and a temporary catheter inserted. A new cuffed catheter may be placed if the patient 
remains afebrile for at least 48-72 hours. 
11.3. Infection of thoracic aorta 
The incidence of infections affecting thoracic or thoracoabdominal aortic grafts, ranges from 
0.5% to 1.9%. Complications can be fatal, and mortality is high. Open surgical repair for 
primary or secondary thoracic aorta infections are associated with significant mortality and 
morbidity. Graft excision and extra-anatomic bypass are usually not applicable to infections 
involving ascending, transverse arch or descending aorta grafts. For most of these cases, in-
situ replacement with the use of prosthetic grafts is the treatment of choice. The use of 
silver-bonded or antimicrobial-bonded synthetic grafts is possibly preferable. Surgical 
debridement and antibacterial irrigation of infected tissues are important. It is reported that 
coverage of the graft with pericardial fat, rotated muscles (e.g. pectoralis major, latissimus 
dorsi, rectus abdominis) or with a pedicle of greater omentum can prevent recurrent 
infections. [57] Antibiotic coverage is necessary. Mortality is reported to be 10-20% while 
reinfection rates 20%. [57,58] The only extra-anatomic repair, that may be recommended, is 
prosthetic grafting from the ascending to abdominal aorta, tunnelling through the 
diaphragm, with subsequent infected graft excision through a left thoracotomy. 
Limited surgical strategy involving extensive mediastinal debridement is reported in cases 
where infection is associated with sternal wound infection by low virulent pathogens. [59] 
Endovascular stent graft repair has been reported as an attractive and effective treatment 
option, but the persistence of infection is always a concern. Though in cases of severe local 
inflammation, with or without haemorrhage, this technique can serve as bridging therapy. [60] 
Stent or stent-graft infections in the thoracic aorta are extremely rare. They are usually met 
in the literature as complications of systemic specific infections such as TBC or brucellosis. 
The general principles of treatment are similar to the thoracic graft infection. Some papers 
report secondary stent-graft infections after TEVAR due to aorto-oesophageal or aorto-
bronchial fistulas. 
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11.4. Vascular infections in the groin  
Infections after vascular reconstructions are most common in the groins. The main 
predisposing factors are surgical division of lymphatic channels, infected lymph glands, the 
superficial location of vascular grafts and the proximity of the surgical site to the perineum. 
A number of serious complications can arise such as fistula, septic hemorrhage, septic 
embolism and limb threatening ischemia. [61,62] Imaging of the infected area is essential for 
the diagnosis. (Figure 3.)  
 
Figure 3. CT findings in a patient with Szilagyi III infection in the groin. (1=fistula, 2=perigraft 
inflammation/secretion, 3=graft) 
There is a lot of controversy about the treatment of choice in groin infections, following 
vascular graft placement. It depends on the degree of graft involvement. If there is no graft 
infection (Szilagyi grade I or II), then wound debridement or drainage with culture-directed 
antibiotic administration is considered to be adequate. If, graft contamination is present 
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(Szilagyi grade III), then further treatment is controversial. In the majority of the cases, 
treatment includes excision of the graft, surgical debridement of the infected tissues 
followed by restoration of blood flow by in situ or extra-anatomic reconstruction.[63,64] 
Obturator or lateral femoral bypass are the most frequent extra-anatomic procedures for 
limb revascularization in vascular groin infections. [65-67]  An 80% cumulative patency rate 
at 6 years has been reported. [68]   However, many concerns have been associated to extra-
anatomic bypass including lengthy procedure time, difficulty of extra-anatomic routing, 
high amputation rates. [69]. When in-situ reconstruction is selected, cryopreserved aortic 
homograft, autologous deep femoral vein, or rifampin-bonded prostheses can serve as 
grafts. Disadvantages associated with in situ reconstructions, include lengthier operative 
time in case of vein harvesting and contraindication in patients with previous deep vein 
thrombosis, high complication rates of cryopreserved allografts and lack of availability in 
emergent cases. In situ reconstructions are associated with higher stress than extra-anatomic 
bypasses, which is important in high risk patients. 
Graft preservation is considered an option when the graft is patent, the entire length of the 
graft is not involved by the infection, the anastomosis is intact, there are no systemic signs of 
sepsis and the contaminating organism is not a virulent strain of bacteria, especially MRSA 
and Pseudomonas aeruginosa . [70,71] 
The use of local muscle flaps to promote wound healing and vascular graft salvage has been 
well documented. [72-74]  
VAC therapy has been reported as an adjunctive or definitive treatment for groin infections 
involving exposed grafts especially in high-risk surgical patients who are not candidates for 
graft replacement. VAC therapy along with aggressive debridement, antibiotic therapy and 
muscle flap coverage may be an effective alternative to current management strategies. 
Some authors recommend the use of V.A.C. even after graft replacement, in treatment of 
Szilagyi III infections. (Figure 4.) 
The majority of current clinical evidence supporting the use of negative pressure therapy 
(VAC) on infected groin wounds following vascular reconstructions has been based on 
clinical experience and small cohort studies. However graft/patch salvage rates up to 97.2%, 
have been reported. [75]. 
11.5. Infection of femoral, popliteal, tibial grafts 
Infection of infrainguinal grafts is quite rare but it can present with anastomotic disruption 
and septic hemorrhage or emboli. The preferred method of treatment is usually graft 
excision and revascularization with bypass grafting via adjacent or remote tunneling. In-situ 
revascularization is feasible in 80% of the cases. The use of autogenous vein grafts is 
preferred when they are available. Some authors advocate staged treatment. In this case, 
closure of the arteriotomies with monofilament suture and the administration of systemic 
and topical antibiotics follow the removal of the graft. Patients who had prosthetic grafts 
inserted for claudication or patients who do not develop limb-threatening ischemia after 
graft excision may not need revascularization.  
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Figure 4. Application of vacuum-assisted closure technique (VAC technique) in a patient with graft 
infection in groin (A=Szilagyi III infection with cutaneous fistula, B=marking of infected area with use of 
methylene blue, C=Wound debridement and replacement of infected graft with a silver-bonded 
synthetic graft, D=preparation of sartorius muscle, E= coverage of the graft with the muscle flap, 
D=Application of VAC system 
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Graft preservation is reported as an alternative option, especially in high risk patients, 
unless there is sepsis or anastomotic bleeding. In such cases local treatment with surgical 
debridement, antibiotic administration and muscle flap coverage is applied. [19,30] 
Treatment of peripheral grafts infection shows low mortality rates ( 0-9%) but increased 
amputation rates (33-67%) compared to treatment of aortic grafts infection. [11,76] 
11.6. Endovascular stent-graft and stent infections 
Infections involving endoluminal devices (stents or stent-grafts) are rare, although they 
present with increased frequency. The reported incidence after AAA repair is 0.2% to 1.2%. 
Infection of peripheral bare stents are extremely rare (<0.1%). They present clinically with 
sepsis, septic emboli, mycotic aneurysm or GEE/GEF. Periprocedural bacteremia from 
remote sites of infection or during secondary endovascular interventions is considered to be 
the cause of stent-graft contamination. [77] Perigraft inflammation or fluid is the main CT 
findings with diagnostic sensitivity of 85%. Treatment consists of antibiotics and graft 
excision followed by extra-anatomic bypass or in situ autogenous replacement. Mortality is 
high and ranges between 20-30%. [78,79]  Endovascular treatment should be considered 
only as a bridging therapy. [80,81] 
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